Skip to main content

Prescription medicine

Sodium thiosulfate Brand names: Pedmark

Sodium thiosulfate (Pedmark) is a prescription medicine with an FDA approval on record since 1992. No generic is listed in FDA's NDC Directory.

  • No generic listed

Check it at the source: the sodium thiosulfate FDA label on DailyMed (effective May 26, 2026, Hope Pharmaceuticals); the NDA 20166 record on Drugs@FDA; every sodium thiosulfate label on DailyMed.

Highlights of the record

FDA label of May 26, 2026; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026

Used for

From the label: indications and usage

Sodium Thiosulfate Injection is indicated for sequential use with sodium nitrite for the treatment of acute cyanide poisoning that is judged to be serious or life-threatening.

Forms and strengths

  • 12.5 g/100ml
  • 250 mg/ml

Injection (solution).

On the market

Earliest approval on file
February 14, 1992 Sodium Thiosulfate, Us Army; Drugs@FDA’s file, where older or withdrawn approvals can be missing
Generic approvals
No generic approved
Labelers listed (NDC)
2 of which 0 under generic applications, 2 under brand applications, repackagers included
Last listed patent
March 29, 2031 Sodium Thiosulfate injection; not a generic launch date

Supply and safety

Pharmacy cost (NADAC)
Not in the survey
Shortage (FDA)
No current entry
Recalls by its makers (FDA)
No recall recorded
FAERS reports
540 through July 30, 2026

What is sodium thiosulfate used for?

From the label: indications and usage

Sodium Thiosulfate Injection is indicated for sequential use with sodium nitrite for the treatment of acute cyanide poisoning that is judged to be serious or life-threatening. When the diagnosis of cyanide poisoning is uncertain, the potential risks associated with Sodium Thiosulfate Injection should be carefully weighed against the potential benefits, especially if the patient is not in extremis. Sodium Thiosulfate Injection, an antidote, is indicated for sequential use with sodium nitrite for treatment of acute cyanide poisoning that is judged to be serious or life-threatening. ( 1 ) Use with caution if the diagnosis of cyanide poisoning is uncertain.

Source: FDA drug label (Sodium Thiosulfate), Hope Pharmaceuticals, effective May 26, 2026 (SPL set 82f55408-2de9-463d-85e8-b39c3b259f0b), via openFDA; the full label on DailyMed

Is there a generic for sodium thiosulfate (Pedmark)?

No generic sodium thiosulfate is approved (Drugs@FDA, October 8, 2026).

The Orange Book lists 6 patents for Sodium Thiosulfate injection: the compound patent runs to March 29, 2031; a patent listed only for Pedmark injection runs to July 1, 2039. A patent or exclusivity date is not the date a generic goes on sale: court cases and settlements move it either way.

  • 1992 earliest approval on file
  • 2031 last listed patent

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

What does the sodium thiosulfate label say about other medicines?

The sodium thiosulfate label names no other medicine on this site. The labels of 2 other medicines name sodium thiosulfate. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.

Other labels that name sodium thiosulfate

Check sodium thiosulfate against other medicines

Source: FDA drug label (Sodium Thiosulfate), Hope Pharmaceuticals, effective May 26, 2026 (SPL set 82f55408-2de9-463d-85e8-b39c3b259f0b), via openFDA; the full label on DailyMed

What do FAERS reports show for sodium thiosulfate?

The FDA Adverse Event Reporting System holds 540 reports that list sodium thiosulfate among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 78 are coded as a death and 189 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.

Reports received each year

The most reported reactions

  • Off Label Use (a use or a product term, not a reaction)145
  • Calciphylaxis86
  • Nausea (named in the label)85
  • Drug Ineffective (a use or a product term, not a reaction)53
  • Vomiting (named in the label)52
  • Metabolic Acidosis31
  • Sepsis22
  • Condition Aggravated (a use or a product term, not a reaction)21

Side effects: the label's list and every FAERS reaction

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026

What next?

Sodium thiosulfate side effects
the label's list beside FAERS reports
Check an interaction
what two or more labels say about each other